The board of directors at CRISPR Therapeutics is made up of experienced professionals from a variety of industries and fields of study. Members of the board have worked as senior partners at McKinsey and Company, fellows at renowned hospitals such as University of California, San Francisco, and residents at Johns Hopkins Hospital. In terms of education, the board members hold degrees from Ivy League schools such as Harvard University. Consequently, the board of directors at CRISPR Therapeutics is highly qualified to make decisions regarding the company's direction and strategy.
View all